Cargando…

Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2

SARS-CoV-2 continues to widely circulate in populations globally. Underdetection is acknowledged and is problematic when attempting to capture the true prevalence. Seroprevalence studies, where blood samples from a population sample are tested for SARS-CoV-2 antibodies that react to the SARS-CoV-2 v...

Descripción completa

Detalles Bibliográficos
Autores principales:	McConnell, David, Hickey, Conor, Bargary, Norma, Trela-Larsen, Lea, Walsh, Cathal, Barry, Michael, Adams, Roisin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123865/ https://www.ncbi.nlm.nih.gov/pubmed/33925518 http://dx.doi.org/10.3390/ijerph18094640

Ejemplares similares

Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
por: Leahy, Joy, et al.
Publicado: (2020)

Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis
por: McConnell, David, et al.
Publicado: (2022)

SARS-CoV-2 infection in general practice in Ireland: a seroprevalence study
por: O'Callaghan, Michael E, et al.
Publicado: (2021)

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
por: Roarty, Cathal, et al.
Publicado: (2021)

The use of continuous data versus binary data in MTC models: A case study in rheumatoid arthritis
por: Schmitz, Susanne, et al.
Publicado: (2012)

Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimates
por: Brown, Tyler S., et al.
Publicado: (2021)

Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
por: Larremore, Daniel B, et al.
Publicado: (2021)

The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome
por: Anderson, Roy M., et al.
Publicado: (2021)

Understanding uncertainty
por: Lindley, Dennis V
Publicado: (2013)

Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting
por: Carey, Niamh, et al.
Publicado: (2023)

SARS-CoV-2 seroprevalence among healthcare workers
por: Wiggen, Talia D., et al.
Publicado: (2022)

Understanding human behavior : an introduction to psychology
por: McConnell, James V.
Publicado: (1974)

Understanding human behavior: an introduction to psychology
por: McConnell, James V
Publicado: (1974)

SARS-CoV-2 seroprevalence in Spain
por: George, Thukalan Paulose
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain
por: Hoffmann, Christian, et al.
Publicado: (2020)

HTA257 MOVe-OUT: A Trial of Two Halves – The Impact of Heterogeneity on Cost-Effectiveness Outcomes for COVID-19
por: McConnell, D, et al.
Publicado: (2022)

Cytomegalovirus Infection in Ireland: Seroprevalence, HLA Class I Alleles, and Implications
por: Hassan, Jaythoon, et al.
Publicado: (2016)

A model for understanding teachers’ intentions to remain in STEM education
por: McConnell, John R.
Publicado: (2017)

The seroprevalence of SARS-CoV-2 in patients on haemodialysis
por: Mahalingasivam, Viyaasan, et al.
Publicado: (2020)

Seroprevalence and presentation of SARS-CoV-2 in pregnancy
por: Crovetto, Francesca, et al.
Publicado: (2020)

The SARS-COV-2 Seroprevalence among Oncology Patients
por: Kgatle, Mankgopo, et al.
Publicado: (2023)

Study of seroprevalence of SARS‐CoV‐2 in Kazakhstan
por: Kulimbet, Mukhtar, et al.
Publicado: (2023)

Cognitive functional therapy compared with a group-based exercise and education intervention for chronic low back pain: a multicentre randomised controlled trial (RCT)
por: O'Keeffe, Mary, et al.
Publicado: (2020)

Preoperative psychosocial risk factors for poor outcomes at 1 and 5 years after total knee replacement: A cohort study of 266 patients
por: Wylde, Vikki, et al.
Publicado: (2017)

Self‐concept, creativity and developmental dyslexia in university students: Effects of age of assessment
por: Brunswick, Nicola, et al.
Publicado: (2022)

Evaluating the neonatal BCG vaccination programme in Ireland
por: Usher, Cara, et al.
Publicado: (2016)

SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia
por: Lau, Jillian SY, et al.
Publicado: (2021)

Estimating the seroprevalence of SARS-CoV-2 antibodies: Understanding population-level immunity in Albania at the end of the Alpha variant wave
por: Cenko, Fabian, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in COVID-19 hotspots
por: Eckerle, Isabella, et al.
Publicado: (2020)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

SARS-CoV-2 Seroprevalence Among Parturient Women
por: Flannery, Dustin D., et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees
por: Hanage, William P, et al.
Publicado: (2020)

Potential drawbacks of SARS-CoV-2 seroprevalence surveys
por: Lippi, G.
Publicado: (2021)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
por: Alharbi, Naif Khalaf, et al.
Publicado: (2021)

Update on SARS-CoV-2 seroprevalence: regional and worldwide
por: Rostami, Ali, et al.
Publicado: (2021)

Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia
por: Krieger, Ekaterina, et al.
Publicado: (2022)

German and international studies on SARS-CoV-2 seroprevalence
por: Poethko-Müller, Christina, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in the Vatican City State
por: Ralli, Massimo, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in South Korea
por: Lee, Kwangmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iq78gr0geffnn38kqnin8r8p1r